Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.21 USD | -0.34% | -3.67% | -10.11% |
30/04 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
30/04 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.11% | 1.66B | |
+32.00% | 694B | |
+29.39% | 593B | |
-1.74% | 371B | |
+19.99% | 331B | |
+6.91% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+7.92% | 169B |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Raymond James Adjusts Price Target on Harmony Biosciences to $58 From $62, Maintains Outperform Rating